1. Home
  2. PGEN vs SRTA Comparison

PGEN vs SRTA Comparison

Compare PGEN & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • SRTA
  • Stock Information
  • Founded
  • PGEN 1998
  • SRTA 2014
  • Country
  • PGEN United States
  • SRTA United States
  • Employees
  • PGEN N/A
  • SRTA N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • SRTA
  • Sector
  • PGEN Health Care
  • SRTA
  • Exchange
  • PGEN Nasdaq
  • SRTA Nasdaq
  • Market Cap
  • PGEN 493.0M
  • SRTA 438.4M
  • IPO Year
  • PGEN N/A
  • SRTA N/A
  • Fundamental
  • Price
  • PGEN $4.78
  • SRTA $4.76
  • Analyst Decision
  • PGEN Buy
  • SRTA Strong Buy
  • Analyst Count
  • PGEN 5
  • SRTA 1
  • Target Price
  • PGEN $7.67
  • SRTA $7.25
  • AVG Volume (30 Days)
  • PGEN 4.5M
  • SRTA 792.3K
  • Earning Date
  • PGEN 11-13-2025
  • SRTA 11-10-2025
  • Dividend Yield
  • PGEN N/A
  • SRTA N/A
  • EPS Growth
  • PGEN N/A
  • SRTA N/A
  • EPS
  • PGEN N/A
  • SRTA 0.50
  • Revenue
  • PGEN $6,309,000.00
  • SRTA $268,618,000.00
  • Revenue This Year
  • PGEN $249.10
  • SRTA N/A
  • Revenue Next Year
  • PGEN $710.03
  • SRTA $28.16
  • P/E Ratio
  • PGEN N/A
  • SRTA $10.24
  • Revenue Growth
  • PGEN 59.20
  • SRTA 70.11
  • 52 Week Low
  • PGEN $0.65
  • SRTA $3.85
  • 52 Week High
  • PGEN $5.23
  • SRTA $6.02
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 68.44
  • SRTA N/A
  • Support Level
  • PGEN $3.74
  • SRTA N/A
  • Resistance Level
  • PGEN $4.04
  • SRTA N/A
  • Average True Range (ATR)
  • PGEN 0.33
  • SRTA 0.00
  • MACD
  • PGEN 0.02
  • SRTA 0.00
  • Stochastic Oscillator
  • PGEN 75.11
  • SRTA 0.00

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About SRTA Strata Critical Medical Inc. Class A Common Stock

Strata Critical Medical Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs.

Share on Social Networks: